In a video interview with CURE, Dr. Elizabeth K. Lee explained that how a treatment affects daily life matters as much as how well it works.
|Articles|July 14, 2023
Ductal Carcinoma in Situ (“Stage Zero” Breast Cancer): What You Need To Know
Advertisement
Ductal carcinoma in situ (DCIS) refers to when cells in the breast duct become cancer cells. This is also known as “stage zero” breast cancer. DCIS is a very early stage of cancer and as a result it is considered to be highly treatable. It is also non-invasive, as the cancerous cells have not spread to other tissue areas in the body.
DCIS does not usually present with noticeable symptoms. Though uncommon, some patients have reported experiencing discharge from the nipples or feeling a lump in the breast. Detection and diagnoses have increased since the increased implementation of routine mammogram screenings. Today, DCIS accounts for between 20-25% of breast cancer diagnoses.
Advertisement
Related to this article
In the phase 3 ASAC trial, daily aspirin did not lower the risk of colorectal cancer returning after treatment for liver metastases, and serious side effects were more common.
Dr. Neel Chudgar of Montefiore Einstein answers the most searched questions about lung cancer surgery, including risks, recovery and recurrence.
Challenge yourself after cancer by building healthier habits, strengthening relationships, managing stress and embracing new experiences for a healthier life.
Rinatabart sesutecan shrank tumors in 45.9% of patients with platinum-resistant ovarian cancer in a phase 2 study, with responses lasting a median of 12.1 months.
The FDA withdrew Zepzelca’s accelerated approval for small cell lung cancer after the LAGOON trial failed to show longer survival. Its maintenance use with Tecentriq is unaffected.
Prostate cancer grows slowly, and while 50% of men on active surveillance eventually need treatment, waiting can mean years without side effects.
Liver and bile duct cancer treatment has changed quickly since 2021, with new immunotherapy combinations, targeted pills and a new radiation option. Here's what's been approved and what it means for patients.
Advertisement
Advertisement
Trending on CURE
1
Why PSA Monitoring Matters After a Prostate Cancer Diagnosis
2
FDA Withdraws Zepzelca Approval for Previously Treated Small Cell Lung Cancer
3
Life After Cancer: Challenge Yourself to Build Healthier Habits and Stronger Relationships
4
The Cancer Search Bar: Top Lung Cancer Surgery Questions Answered
5